CryoLife to Participate in the UBS Global Healthcare Virtual Conference

Rhea-AI Summary

CryoLife, Inc. (NYSE: CRY), a leader in cardiac and vascular surgery, will participate in the UBS Global Healthcare Virtual Conference on May 25, 2021. The company's fireside chat is set for 11:00 a.m. ET. Investors can access a live webcast on CryoLife's website, along with an archived version available for 90 days post-event. Headquartered in Atlanta, CryoLife specializes in medical devices for aortic repair and has a global market presence in over 100 countries.

News Market Reaction – CRY

+1.93%

+1.93% Session move

In the trading session that priced this news, CRY gained 1.93%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021. The Company's virtual fireside chat is scheduled to begin at 11:00 a.m. ET.  

A live webcast of the virtual fireside chat will be accessible through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website. 

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:
CryoLife	Gilmartin Group LLC
D. Ashley Lee	Brian Johnston / Lynn Lewis
Executive Vice President, Chief Financial Officer and Chief Operating Officer	Phone: 631-807-1986  investors@cryolife.com
Phone: 770-419-3355

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-to-participate-in-the-ubs-global-healthcare-virtual-conference-301293517.html

SOURCE CryoLife, Inc.

FAQ

What is CryoLife's participation in the UBS Global Healthcare Virtual Conference on May 25, 2021?

CryoLife will participate in the UBS Global Healthcare Virtual Conference with a fireside chat scheduled at 11:00 a.m. ET.

Where can I access the webcast of CryoLife's fireside chat during the conference?

The webcast will be available on CryoLife's website on the Investor Relations page.

How long will the archived version of CryoLife's webcast be available?

The archived version of CryoLife's webcast will be available for 90 days after the event.

What products does CryoLife focus on in the medical device market?

CryoLife specializes in manufacturing devices and tissues used in cardiac and vascular surgical procedures, especially for aortic repair.

In how many countries does CryoLife operate?

CryoLife markets its products in over 100 countries worldwide.